APPLICATIONS PUBLISHED 11 FEBRUARY 2004

Published: 1-Aug-2004

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492

  • Immune modulation device for use in animals
    Ortho-McNeill Pharmaceutical 1387670*

  • Implantable drug delivery device and use thereof
    Massachusetts Eye & Ear Infirmary; The Charles Stark Draper Laboratory 1387671*

  • Flavoured product containing medicament or other active agent
    WM Wrigley Jr Company 1387672*

  • Abuse-resistant controlled-release opioid dosage form
    Endo Pharmaceuticals 1387673*

  • Hedgehog antagonists, methods and uses related thereto
    Curis 1387674*

  • Liquid formulation of metformin
    Ranbaxy Signature 1387675*

  • Compsns comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions
    Angiotech Pharmaceuticals 1387676*

  • Methods of treating haematologic tumours and cancers using beta lapachone
    Dana-Farber Cancer Institute 1387677*

  • Compounds that inhibit HSP90 and stimulate HSP70 and HSP40, useful in the prevention or treatment of diseases associated with protein aggregation and amyloid formulation
    Max-Planck-Gesellschaft zur Foerderung der Wissenschaften 1387678*

  • Sulphonamides
    SmithKline Beecham 1387679*

  • Benzimidazole derivatives as therapeutic agents
    TransTech Pharma 1387680*

  • Antiviral compounds
    Virogen 1387681*

  • Treatment of ADHD
    H Lundbeck 1387682*

  • Novel salt and crystalline forms of (2R)-anti-5,3-(4-(10,11-difluoromethanodibenzosuber-5-yl)piperazin-1-yl)-2-hydroxypropoxy quinoline
    Eli Lilly 1387683*

  • Compsns comprising lopinavir and methods for enhancing the bio-availability of pharmaceutical agents
    Abbott Laboratories 1387684*

  • Analgesic compsn and method
    Wex Medical Instrumentation 1387685*

  • Timing and duration of administration of adenosine A1/A2 agonist for cardioprotection
    Aventis Pharmaceuticals 1387686*

  • Novel use
    SmithKline Beecham 1387687*

  • Benzazepinone alpha V integrin receptor antagonists
    Merck 1387688*

  • Combination of a gelatinase inhibitor and an anti-tumour agent, and uses thereof
    F Hoffmann-la Roche 1387689*

  • Use of extracts and preparations from iris plants and tectorigenin as medicaments
    Bionorica 1387690*

  • Blood coagulation factor XIII for treating platelet disorders
    ZymoGenetics 1387691*

  • Molecular interactions in hematopoietic cells
    Arbor Vita Corp 1387692*

  • Saponin inactivated mycoplasma vaccine
    Novartis 1387693*

  • Compsn and method for treating cancer using herpes virus
    M'S Science Corp 1387694*

  • Myostatin immunoconjugate and its use for immunisation
    Regents of the University of Minnesota 1387695*

  • Anti-IGE antibody to treat ocular allergies
    Novartis 1387696*

  • Methods of treating antibody-mediated pathologies using agents which inhibit CD21
    La Jolla Pharmaceutical 1387697*

  • Method of preventing cell death using antibodies to treat neural thread proteins
    Nymox Corp 1387698*

  • Agent for improving tissue penetration
    Max-Planck-Gesellschaft zur Foerderung der Wissenschaften 1387699*

  • Methods and devices for moisturising hyperpolarised noble gases and pharmaceutical products thereof
    Medi-Physics 1387700*

  • Immunoconjugates made of egg-yolk antibodies (IGY), production and use thereof in diagnostics and therapy
    Bergter, Wolfgang; Kobilke, Hartmut; Sroka, Joachim 1387701*

  • Method and compsn for reducing bacterial attachment to biomaterials
    Bausch & Lomb 1387702*

  • Oestrogen receptor modulators
    Merck 1387821*

  • 2-[4-(2,2-dihalocyclopropyl)phenoxy]-alkanoic acids and esters thereof production process
    Laboratorio Chimico Internazionale 1387822*

  • Thyroid hormone receptor antagonists for cardiac & metabolic disorders II
    Karo Bio 1387825*

  • Novel 5-phenyl-1H-indole derivatives as antagonists of interleukine-8 receptors
    Laboratoires Fournier 1387826*

  • Synthesis of cyclopentadiene derivatives
    Basell Polyolefin 1387827*

  • Method for producing biperiden IV
    Abbott 1387828*

  • Novel pyridinone and related heterocyclic derivatives
    AstraZeneca 1387829*

  • Novel 4-anilinoquinoline-3-carboxamides
    AstraZeneca 1387830*

  • Substituted arylketones
    Bayer CropScience 1387831*

  • Method for the production of 1-amino-3-phenyl-uracil derivatives
    Bayer CropScience 1387832*

  • Protease inhibitors
    Graffinity Pharmaceuticals Aktiengesellschaft 1387833*

  • A process for lactonisation to produce highly pure simvastatin
    Aurobindo Pharma 1387835*

  • Phthalazine derivatives with angiogenesis inhibiting activity
    Novartis 1387836*

  • Novel azole or triazole derivatives, method for preparing same and use thereof as antifungal medicines
    Aventis Pharma 1387837*

  • Cyanoanthranilamide derivatives and the use thereof as medicaments
    Schering AG 1387838*

  • Process for the production of quinazolines
    Pfizer 1387839*

  • 3,5-diamino-1,2,4-triazoles as kinase inhibitors
    Schering 1387840*

  • Novel azole or triazole derivatives, method for preparing the same, and use thereof as fungicides
    Aventis Pharma 1387841*

  • Broad spectrum 2-amino-benzoxazole sulphonamide HIV protease inhibitors
    Tibotec Pharmaceuticals 1387842*

  • Method for obtaining pioglitazone as an antidiabetic agent
    Leciva 1387843*

  • Retinol derivatives potentiation of active substances by micellar preparation
    Ardenia Investments 1387844*

  • Processes for 2,3-dihydro-1,4-dioxino-(2,3-F) quinoline
    Wyeth 1387845*

  • Catalyst for enantioselective reduction of ketones
    Centre National de la Recherche Scientifique 1387846*

  • Enantiomers of unsaturated alkylsophosphonocholines and use as antineoplastics
    The Research Foundation of the City University of New York; The University of Manitoba 1387847*

  • Process for the preparation of EP(D)M elastomeric copolymers and terpolymers
    Polimeri Europa 1387848*

  • Polymerisation catalyst
    BP Chemicals 1387849*

  • Antiviral nucleosides
    Kumar, Rakesh 1387850*

  • Process for the synthesis of oxanodrolone
    Cedarburg Pharmaceuticals 1387851*

  • Method for producing and identifying appropriate effectors of target molecules using substance libraries
    Nanogen Recognomics 1387853*
  • You may also like